Non-homologous recombination of deoxyribonucleoside kinases from human and Drosophila melanogaster yields human-like enzymes with novel activities

Eitemau Tebyg

• Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells
  gan: Fatima, Mahak, et al.
  Cyhoeddwyd: (2019)
• Mutagenesis of non-conserved active site residues improves the activity and narrows the specificity of human thymidine kinase 2
  gan: Gerth, Monica L., et al.
  Cyhoeddwyd: (2007)
• Synergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma in vitro and in vivo
  gan: Tang, Miao, et al.
  Cyhoeddwyd: (2015)
• Isolation of Su(var)3-7 mutations by homologous recombination in Drosophila melanogaster.
  gan: Seum, Carole, et al.
  Cyhoeddwyd: (2002)
• Recombineering Homologous Recombination Constructs in Drosophila
  gan: Carreira-Rosario, Arnaldo, et al.
  Cyhoeddwyd: (2013)